Fresenius continues steady growth
This article was originally published in Clinica
Executive Summary
Nine-month results for German dialysis company Fresenius show a sales increase of 11% to DM 1,651 million ($1,158 million) compared with last year. In constant currencies the increase would have been 16%, but the strong mark forced the figure down. The company expects sales to grow 10% in the full year.